MITA commends CT cost study in Health Affairs
Article Thumbnail ImageApril 10, 2012 -- The Medical Imaging and Technology Alliance (MITA) has applauded an actuarial cost-benefit analysis conducted by Milliman, which found that low-dose spiral CT of individuals at high risk for lung cancer would save thousands of lives at a relatively low cost if the procedure were routinely covered by commercial insurers.
Member Sign In:
MemberID or E-mail Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  



The Milliman study, published in the April 2012 issue of Health Affairs, examined the costs and benefits of providing lung cancer screening through low-dose CT to commercially insured high-risk individuals, targeting smokers and long-term former smokers ages 50 to 64 years.

Based on current commercial reimbursement rates for treatment, researchers concluded CT screening would cost approximately $1 per insured member per month in 2012. The study also estimated that the cost per life-year saved would be less than $19,000, which is less than screening for cervical and breast cancer and comparable to the cost per life-year saved of screening for colorectal cancer.